Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
Delaware District Court | |
Judge: | Maryellen Noreika |
Case #: | 1:24-cv-01192 |
Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
Cause | 35:271 Patent Infringement |
Case Filed: | Oct 24, 2024 |
Terminated: | Mar 21, 2025 |
Last checked: Tuesday Apr 22, 2025 4:31 AM EDT |
Defendant
Boehringer Ingelheim International GmbH
|
Represented By
|
Defendant
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Represented By
|
Defendant
Boehringer Ingelheim Pharmaceuticals Inc.
|
Represented By
|
Plaintiff
Sandoz Inc.
|
Represented By
|
Docket last updated: 2 hours ago |
Friday, March 21, 2025 | ||
20 | 20
![]() Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,907,756; US 10,105,323.(as) |
|
Att: 1
![]() |
||
19 | 19
![]() CONSENT DECREE AND FINAL JUDGMENT. Signed by Judge Maryellen Noreika on 3/21/2025. (dlw) |
|
Thursday, March 20, 2025 | ||
18 | 18
![]() PROPOSED CONSENT JUDGMENT -- Consent Decree and Final Judgment -- by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
Friday, March 07, 2025 | ||
17 | 17
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 21, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Fri 03/07 11:18 AM
SO ORDERED re17 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 21, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 3/21/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 3/21/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 3/21/2025). ORDERED by Judge Maryellen Noreika on 3/7/2025. (dlw) |
||
Tuesday, March 04, 2025 | ||
16 | 16
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 7, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Tue 03/04 3:01 PM
SO ORDERED re16 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 7, 202 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 3/7/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 3/7/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 3/7/2025). ORDERED by Judge Maryellen Noreika on 3/4/2025. (dlw) |
||
Tuesday, February 25, 2025 | ||
15 | 15
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 4, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Tue 02/25 1:48 PM
SO ORDERED re15 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to March 4, 202 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 3/4/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 3/4/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 3/4/2025). ORDERED by Judge Maryellen Noreika on 2/25/2025. (dlw) |
||
Monday, February 10, 2025 | ||
14 | 14
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 25, 2025 - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Tigan, Jeremy) |
|
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Mon 02/10 3:15 PM
SO ORDERED re14 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 25, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 2/25/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 2/25/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 2/25/2025). ORDERED by Judge Maryellen Noreika on 2/10/2025. (dlw) |
||
Tuesday, January 07, 2025 | ||
order
SO ORDERED ~Util - Set/Reset Answer Deadline
Tue 01/07 11:56 AM
SO ORDERED re13 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 11, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 2/11/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 2/11/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 2/11/2025). ORDERED by Judge Maryellen Noreika on 1/7/2025. (dlw) |
||
Monday, January 06, 2025 | ||
13 | 13
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharma GmbH & Co. KG to move, answer, or otherwise respond to the Complaint (D.I. 2) to February 11, 2025 - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Tigan, Jeremy) |
|
Wednesday, November 20, 2024 | ||
utility
Add Attorneys - PHV only
Wed 11/20 1:56 PM
Pro Hac Vice Attorney Laura A. Lydigsen, Mark H. Remus for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
||
Tuesday, November 19, 2024 | ||
utility
Add Attorneys - PHV only
Tue 11/19 1:59 PM
Pro Hac Vice Attorney April Barnard for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
||
Monday, November 18, 2024 | ||
12 | 12
misc
-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment
Mon 11/18 10:16 AM
Pro Hac Vice Fee - Credit Card Payment received for Mark H. Remus, Laura A. Lydigsen, and April Barnard. ( re11 MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard )( Payment of $ 150, receipt number ADEDC-4550738).(Gattuso, Dominick) |
|
11 | 11
![]() MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard - filed by Sandoz Inc.. (Gattuso, Dominick) |
|
order
SO ORDERED
Mon 11/18 10:58 AM
SO ORDERED re11 MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard filed by Sandoz Inc. ORDERED by Judge Maryellen Noreika on 11/18/2024. (dlw) |
||
Monday, November 04, 2024 | ||
10 | 10
![]() SO ORDERED re9 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 1/9/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 1/9/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 1/9/2025). ORDERED by Judge Maryellen Noreika on 11/4/2024. (dlw) |
|
9 | 9
![]() STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
|
Thursday, October 31, 2024 | ||
8 | 8
![]() REDACTED VERSION of2 Complaint and Exhibits E, F and L by Sandoz Inc.(Gattuso, Dominick) Modified on 10/31/2024 (dlw) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
Wednesday, October 30, 2024 | ||
utility
Case Assigned/Reassigned
Wed 10/30 11:34 AM
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
||
Friday, October 25, 2024 | ||
order
SO ORDERED
Fri 10/25 8:20 AM
SO ORDERED re1 MOTION to Seal - IT IS HEREBY ORDERED that the motion is GRANTED and the Complaint and Exhibits E, F & L may be filed under seal. IT IS FURTHER ORDERED that redacted versions of these documents shall be filed no later than 10/31/2024. ORDERED by Judge Maryellen Noreika on 10/25/2024. (dlw) |
||
Thursday, October 24, 2024 | ||
7 | 7
![]() Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Other Affiliate Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (oam) |
|
6 | 6
![]() Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (oam) |
|
5 | 5
![]() Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/20/2022. Date of Expiration of Patent: 06/4/2029 & 06/07/2029. (oam) |
|
4 | 4
![]() EXHIBIT In Support of D.I.2 Complaint filed by Sandoz Inc.(oam) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
Att: 4
![]() |
||
Att: 5
![]() |
||
Att: 6
![]() |
||
Att: 7
![]() |
||
Att: 8
![]() |
||
Att: 9
![]() |
||
Att: 10
![]() |
||
Att: 11
![]() |
||
Att: 12
![]() |
||
Att: 13
![]() |
||
Att: 14
![]() |
||
Att: 15
![]() |
||
3 | 3
![]() Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
|
2 | 2
![]() [SEALED] COMPLAINT for PATENT INFRINGEMENT filed against Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4531692.) - filed by Sandoz Inc..(oam) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
Att: 4
![]() |
||
1 | 1
![]() MOTION to File Complaint and Exhibits Under Seal - filed by Sandoz Inc.(oam) |
|
Att: 1
![]() |
||
service
No Summons Issued
Thu 10/24 4:21 PM
No Summons Issued. (oam) |
||
utility
Remark
Thu 10/24 4:31 PM
Remark: Exit Electronic Copies to Duty Judge MN. (oam) |